1. Handels RL, Wolfs CA, Aalten P, Joore MA, Verhey FR, Severens JL. Diagnosing Alzheimer's disease: a systematic review of economic evaluations. Alzheimers Dement. 2014; 10:225–237.
2. Bradford A, Kunik ME, Schulz P, Williams SP, Singh H. Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord. 2009; 23:306–314.
3. Lantz PM, House JS, Lepkowski JM, Williams DR, Mero RP, Chen J. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA. 1998; 279:1703–1708.
4. Ortiz F, Fitten LJ. Barriers to healthcare access for cognitively impaired older Hispanics. Alzheimer Dis Assoc Disord. 2000; 14:141–150.
5. Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimäki M, Batty GD. Socioeconomic status as a risk factor for dementia death: individual participant meta-analysis of 86 508 men and women from the UK. Br J Psychiatry. 2013; 203:10–17.
6. Sattler C, Toro P, Schönknecht P, Schröder J. Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease. Psychiatry Res. 2012; 196:90–95.
7. Wilson RS, Scherr PA, Hoganson G, Bienias JL, Evans DA, Bennett DA. Early life socioeconomic status and late life risk of Alzheimer's disease. Neuroepidemiology. 2005; 25:8–14.
8. Livney MG, Clark CM, Karlawish JH, Cartmell S, Negrón M, Nuñez J, Xie SX, Entenza-Cabrera F, Vega IE, Arnold SE. Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center. Am J Geriatr Psychiatry. 2011; 19:430–439.
9. Shin MH, Lee YM, Park JM, Kang CJ, Lee BD, Moon E, Chung YI. A combination of the Korean version of the mini-mental state examination and Korean dementia screening questionnaire is a good screening tool for dementia in the elderly. Psychiatry Investig. 2011; 8:348–353.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 1984; 34:939–944.
11. Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: Systematic review and meta-analysis. BMC Public Health. 2014; 14:643.
12. Bae JB, Kim YJ, Han JW, Kim TH, Park JH, Lee SB, Lee JJ, Jeong HG, Kim JL, Jhoo JH, et al. Incidence of and risk factors for Alzheimer's disease and mild cognitive impairment in Korean elderly. Dement Geriatr Cogn Disord. 2015; 39:105–115.
13. Kim KW, Park JH, Kim MH, Kim MD, Kim BJ, Kim SK, Kim JL, Moon SW, Bae JN, Woo JI, et al. A nationwide survey on the prevalence of dementia and mild cognitive impairment in South Korea. J Alzheimers Dis. 2011; 23:281–291.
14. Qian W, Schweizer TA, Fischer CE. Impact of socioeconomic status on initial clinical presentation to a memory disorders clinic. Int Psychogeriatr. 2014; 26:597–603.
15. Moritz DJ, Petitti DB. Association of education with reported age of onset and severity of Alzheimer's disease at presentation: implications for the use of clinical samples. Am J Epidemiol. 1993; 137:456–462.
16. Roe CM, Xiong C, Grant E, Miller JP, Morris JC. Education and reported onset of symptoms among individuals with Alzheimer disease. Arch Neurol. 2008; 65:108–111.
17. García AM, Ramón-Bou N, Porta M. Isolated and joint effects of tobacco and alcohol consumption on risk of Alzheimer's disease. J Alzheimers Dis. 2010; 20:577–586.
18. Hagger-Johnson G, Sabia S, Brunner EJ, Shipley M, Bobak M, Marmot M, Kivimaki M, Singh-Manoux A. Combined impact of smoking and heavy alcohol use on cognitive decline in early old age: Whitehall II prospective cohort study. Br J Psychiatry. 2013; 203:120–125.
19. Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry. 2009; 17:542–555.
20. Seid AK. Social interactions, trust and risky alcohol consumption. Health Econ Rev. 2015; 6:3.
21. Bloomfield K, Grittner U, Rasmussen HB, Petersen HC. Socio-demographic correlates of alcohol consumption in the Danish general population. Scand J Public Health. 2008; 36:580–588.
22. Agli O, Bailly N, Ferrand C. Spirituality and religion in older adults with dementia: a systematic review. Int Psychogeriatr. 2015; 27:715–725.
23. Coin A, Perissinotto E, Najjar M, Girardi A, Inelmen EM, Enzi G, Manzato E, Sergi G. Does religiosity protect against cognitive and behavioral decline in Alzheimer's dementia? Curr Alzheimer Res. 2010; 7:445–452.
24. Blankevoort CG, van Heuvelen MJ, Boersma F, Luning H, de Jong J, Scherder EJ. Review of effects of physical activity on strength, balance, mobility and ADL performance in elderly subjects with dementia. Dement Geriatr Cogn Disord. 2010; 30:392–402.
25. Rist PM, Marden JR, Capistrant BD, Wu Q, Glymour MM. Do physical activity, smoking, drinking, or depression modify transitions from cognitive impairment to functional disability? J Alzheimers Dis. 2015; 44:1171–1180.
26. Potter R, Ellard D, Rees K, Thorogood M. A systematic review of the effects of physical activity on physical functioning, quality of life and depression in older people with dementia. Int J Geriatr Psychiatry. 2011; 26:1000–1011.
27. Lehmann SW, Black BS, Shore A, Kasper J, Rabins PV. Living alone with dementia: lack of awareness adds to functional and cognitive vulnerabilities. Int Psychogeriatr. 2010; 22:778–784.
28. Sundström A, Westerlund O, Mousavi-Nasab H, Adolfsson R, Nilsson LG. The relationship between marital and parental status and the risk of dementia. Int Psychogeriatr. 2014; 26:749–757.
29. Lin JS, O'Connor E, Rossom RC, Perdue LA, Eckstrom E. Screening for cognitive impairment in older adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013; 159:601–612.
30. Moyer VA; U.S. Preventive Services Task Force. Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 160:791–797.
31. Schwarzkopf L, Menn P, Kunz S, Holle R, Lauterberg J, Marx P, Mehlig H, Wunder S, Leidl R, Donath C, et al. Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage. Value Health. 2011; 14:827–835.
32. Huang YJ, Lin CH, Lane HY, Tsai GE. NMDA neurotransmission dysfunction in behavioral and psychological symptoms of Alzheimer's disease. Curr Neuropharmacol. 2012; 10:272–285.
33. Standridge JB. Pharmacotherapeutic approaches to the prevention of Alzheimer's disease. Am J Geriatr Pharmacother. 2004; 2:119–132.
34. Yu SY, Lee TJ, Jang SH, Han JW, Kim TH, Kim KW. Cost-effectiveness of nationwide opportunistic screening program for dementia in South Korea. J Alzheimers Dis. 2015; 44:195–204.